Using graphene quantum dots for advanced imaging in living animals
Biocompatible Graphene Quantum Dots for Noninvasive Near-infrared Bioimaging
This study is working on a new imaging tool using tiny particles called graphene quantum dots to help doctors see deep inside the body more clearly, which could improve how we find and treat tumors in live animals.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Christian University NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project ID | NIH-10203022 on NIH RePORTER |
What this research studies
This research focuses on developing a new imaging platform using graphene quantum dots (GQDs) that can enhance near-infrared (NIR) imaging techniques. By synthesizing and testing these GQDs, the project aims to create a biocompatible and multifunctional tool for deep tissue imaging, which is crucial for better diagnostics and therapeutic tracking in live animal models. The approach involves synthesizing the GQDs, assessing their safety and effectiveness in imaging, and ultimately applying them in live animal studies to visualize tumors and track drug delivery. This innovative method could significantly improve the accuracy and depth of imaging compared to traditional techniques.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research would be individuals requiring advanced imaging techniques for conditions that are difficult to visualize with current methods.
Not a fit: Patients who do not require imaging or those with conditions that are not addressed by NIR imaging may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and less invasive imaging techniques for diagnosing and monitoring diseases in patients.
How similar studies have performed: While the use of NIR imaging is a developing field, similar approaches using biocompatible materials have shown promise in enhancing imaging techniques in other studies.
Where this research is happening
Fort Worth, United States
- Texas Christian University — Fort Worth, United States (Active)
Researchers
- Principal investigator: Naumov, Anton — Texas Christian University
- Study coordinator: Naumov, Anton
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.